326P NeoPancONE: Feasibility of Completing a Neoadjuvant Multicentre Phase II Study in Resectable Pancreatic Ductal Adenocarcinoma (R-Pdac), Treated with Modified FOLFIRINOX (Mffx)
Annals of Oncology(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要